The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
Objective: To compare the diagnostic utility of laboratory variables, including matrix metalloproteinase-3 (MMP-3), anti-cyclic citrullinated peptide (CCP) antibodies, rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) in...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1080/17402520500233510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849309197145997312 |
|---|---|
| author | O. Shovman B. Gilburd G. Zandman-Goddard Y. Sherer H. Orbach R. Gerli Y. Shoenfeld |
| author_facet | O. Shovman B. Gilburd G. Zandman-Goddard Y. Sherer H. Orbach R. Gerli Y. Shoenfeld |
| author_sort | O. Shovman |
| collection | DOAJ |
| description | Objective: To compare the diagnostic utility of laboratory variables,
including matrix metalloproteinase-3 (MMP-3), anti-cyclic citrullinated peptide
(CCP) antibodies, rheumatoid factor (RF), erythrocyte sedimentation rate (ESR),
and C-reactive protein (CRP) in
patients with erosive and non-erosive rheumatoid arthritis (RA). |
| format | Article |
| id | doaj-art-048cab7f33d64ebe87d54ffcc28dd1a4 |
| institution | Kabale University |
| issn | 1740-2522 1740-2530 |
| language | English |
| publishDate | 2005-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Developmental Immunology |
| spelling | doaj-art-048cab7f33d64ebe87d54ffcc28dd1a42025-08-20T03:54:15ZengWileyClinical and Developmental Immunology1740-25221740-25302005-01-0112319720210.1080/17402520500233510The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid ArthritisO. Shovman0B. Gilburd1G. Zandman-Goddard2Y. Sherer3H. Orbach4R. Gerli5Y. Shoenfeld6Center for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, IsraelCenter for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, IsraelCenter for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, IsraelCenter for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, IsraelDepartment of Medicine B Wolfson Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Holon, IsraelDipartmrnt Di Medicina Clinica e Sperimentale, Universita Di Perugia, Sezione di Medicina Interna e Scienze Oncologiche Policlinico Monteluco, Perugia, ItalyCenter for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, IsraelObjective: To compare the diagnostic utility of laboratory variables, including matrix metalloproteinase-3 (MMP-3), anti-cyclic citrullinated peptide (CCP) antibodies, rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) in patients with erosive and non-erosive rheumatoid arthritis (RA).http://dx.doi.org/10.1080/17402520500233510 |
| spellingShingle | O. Shovman B. Gilburd G. Zandman-Goddard Y. Sherer H. Orbach R. Gerli Y. Shoenfeld The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis Clinical and Developmental Immunology |
| title | The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis |
| title_full | The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis |
| title_fullStr | The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis |
| title_full_unstemmed | The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis |
| title_short | The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis |
| title_sort | diagnostic utility of anti cyclic citrullinated peptide antibodies matrix metalloproteinase 3 rheumatoid factor erythrocyte sedimentation rate and c reactive protein in patients with erosive and non erosive rheumatoid arthritis |
| url | http://dx.doi.org/10.1080/17402520500233510 |
| work_keys_str_mv | AT oshovman thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT bgilburd thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT gzandmangoddard thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT ysherer thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT horbach thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT rgerli thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT yshoenfeld thediagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT oshovman diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT bgilburd diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT gzandmangoddard diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT ysherer diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT horbach diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT rgerli diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis AT yshoenfeld diagnosticutilityofanticycliccitrullinatedpeptideantibodiesmatrixmetalloproteinase3rheumatoidfactorerythrocytesedimentationrateandcreactiveproteininpatientswitherosiveandnonerosiverheumatoidarthritis |